Scynexis (SCYX) Revenue Growth (5y) (2018 - 2024)
Scynexis (SCYX) Revenue Growth (5y) (2018 - 2024) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - |
| 2 | Teva Pharmaceutical Industries | 42.98 Bn | 39.33 Bn | 2.15 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.15 Bn | 19.48 Bn | 683.80 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.56 Bn | 15.17 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.74 Bn | 11.21 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - |
| 10 | Scynexis | 62.02 Mn | -52.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 66.80% |
| Mar 31, 2024 | 84.63% |
| Dec 31, 2023 | 146.27% |
| Sep 30, 2023 | 94.05% |
| Jun 30, 2023 | 359.75% |
| Mar 31, 2023 | 77.57% |
| Dec 31, 2022 | 88.52% |
| Sep 30, 2022 | 89.33% |
| Jun 30, 2022 | 83.26% |
| Mar 31, 2022 | 61.36% |
| Dec 31, 2021 | 55.82% |
| Sep 30, 2021 | 51.81% |
| Mar 31, 2021 | 185.08% |
| Jun 30, 2019 | -2.59% |
| Mar 31, 2019 | -57.66% |
| Dec 31, 2018 | 14.99% |
| Sep 30, 2018 | -51.32% |
| Jun 30, 2018 | -56.74% |
| Mar 31, 2018 | -57.82% |